BIT 0.00% 2.5¢ biotron limited

News: Biotron's Hep C drug candidate phase 2a tri, page-5

  1. 765 Posts.
    re: News: Biotron's Hep C drug candidate phas...
    There are a few things to get exited about here...

    >Healthy Volume today.

    >Michelle Millers interveiw alluded to the fact that not only is bit225 compatable with interferon/ribavirin but probably the newer generation of treatments,this means 2 or possibly 3 avenues with seperate pharma heavyweights.

    >They seem confident that they will get the same level of results with HIV.

    GL Holders
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $22.55M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $23.83K 953.1K

Buyers (Bids)

No. Vol. Price($)
2 141000 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 36000 1
View Market Depth
Last trade - 15.15pm 22/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.